XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Total revenue $ 24,933 $ 23,003
Operating costs and expenses:    
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member]
Product costs $ 5,267 $ 4,497
Research and development 12,743 11,663
Selling, general and administrative 13,236 9,192
Acquired intangible asset amortization 913 1,089
Contingent consideration expense 3 3
Total operating costs and expenses 32,162 26,444
Operating loss (7,229) (3,441)
Other expense:    
Interest expense, net (826) (136)
Foreign exchange (loss) gain (125) 33
Investment income, net 172 26
Other expense (779) (77)
Loss before income taxes (8,008) (3,518)
Income tax benefit 165 706
Net loss $ (7,843) $ (2,812)
Basic net loss per share $ (0.56) $ (0.20)
Diluted net loss per share $ (0.56) $ (0.20)
Weighted average number of shares outstanding:    
Basic 13,983 13,878
Diluted 13,983 13,878
Product Sales [Member]    
Revenue:    
Total revenue $ 14,234 $ 12,344
Royalties and License Fees [Member]    
Revenue:    
Total revenue 8,765 8,099
Research, Development and Other [Member]    
Revenue:    
Total revenue $ 1,934 $ 2,560